Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             331 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 7 ABS: What have we learned from long-term results of prostate brachytherapy ? 2004
 71 S2 p. S3-
1 p.
 artikel
2 64 Accelerated partial breast irradiation (APBI): is it ready for prime time ? 2004
 71 S2 p. S32-
1 p.
 artikel
3 65 Accelerated partial breast irradiation (APB): ready for prime time ? 2004
 71 S2 p. S32-S33
2 p.
 artikel
4 Author index 2004
 71 S2 p. S141-S147
7 p.
 artikel
5 59 Brachytherapy as monotherapy in localised prostate cancer, permanent seed implantation or high dose rate ? 2004
 71 S2 p. S29-S30
2 p.
 artikel
6 170 Cervical cancer: experience in the department of radiation oncology. H.U. “Reina Sofia” Cordoba 2004
 71 S2 p. S79-S80
2 p.
 artikel
7 57 Clinical confirmation that “HDR” monotherapy may be the best accelerated-hypofractionated treatment for prostate cancer 2004
 71 S2 p. S28-
1 p.
 artikel
8 27 Clinical validation of TG-43 data treatment planning algorithms 2004
 71 S2 p. S13-
1 p.
 artikel
9 58 Combined external beam radiation and intensity modulated HDR-brachytherapy boost for localized prostate cancer 2004
 71 S2 p. S28-S29
2 p.
 artikel
10 26 Consideration of the updated TG-43 brachytherapy dosimetry formalism 2004
 71 S2 p. S13-
1 p.
 artikel
11 100 Defining low/high dose rate as if biology mattered 2004
 71 S2 p. S50-
1 p.
 artikel
12 29 3D Imaging based treatment planning in brachytherapy, the next generation or what next to TG-43 2004
 71 S2 p. S14-S15
2 p.
 artikel
13 32 Following my way in curie therapy — Tarragona 1950 through Houston 1996 2004
 71 S2 p. S16-
1 p.
 artikel
14 6 GLAC: combined chemoradiotherapy and brachytherapy in locally advanced cervical cancer 2004
 71 S2 p. S3-
1 p.
 artikel
15 61 Interstitial brachytherapy for breast cancer: technical issues & avoiding pitfalls 2004
 71 S2 p. S31-
1 p.
 artikel
16 171 Intracavitary brachytherapy for endometrial cancer. Experience in the department of Radiation Oncology. H.U. “Reina Sofia”, Cordoba 2004
 71 S2 p. S80-
1 p.
 artikel
17 98 LDR brachytherapy 2004
 71 S2 p. S49-
1 p.
 artikel
18 63 Mammosite: technical factors and outcome — European experience 2004
 71 S2 p. S31-S32
2 p.
 artikel
19 76 oral Accelerated partial breast irradiation with 192-iridium multicatheter PDR-/HDR-brachytherapy. 2-year results of the German-Austrian multicenter trial 2004
 71 S2 p. S38-
1 p.
 artikel
20 92 oral A comparison between Paris, SSDS and target optimised dosimetry for interstitial brachytherapy breast boost 2004
 71 S2 p. S46-
1 p.
 artikel
21 12 oral A comparison of automated and manual dose-volume data extraction for HDR prostate patients: implications for tolerance data 2004
 71 S2 p. S5-S6
2 p.
 artikel
22 115 oral Adjuvant HDR brachytherapy after external beam radiotherapy in 182 with nasopharyngeal cancer patients 2004
 71 S2 p. S57-
1 p.
 artikel
23 49 oral Adjuvant treatment with external radiotherapy and high-dose-rate brachytherapy in patients with endometrial tumours previously treated with surgery. Analysis of results and secondary effects 2004
 71 S2 p. S23-S24
2 p.
 artikel
24 16 oral Advanced cervical carcinoma treated by external beam radiotherapy and high dose rate brachytherapy 2004
 71 S2 p. S7-
1 p.
 artikel
25 96 oral A method for checking HDR brachytherapy treatment plans 2004
 71 S2 p. S47-S48
2 p.
 artikel
26 105 oral Analysis of acute and late morbidity, and biochemical control for intermediate to high risk prostate cancer treated with androgen deprivation, HDR and 3D/IMRT: 4 year results of a phase I-II dose escalation trial 2004
 71 S2 p. S52-S53
2 p.
 artikel
27 72 oral An economic evaluation of interstitial brachytherapy, radical prostatectomy and external beam radiotherapy for localized prostate cancer : results during the first year after therapy 2004
 71 S2 p. S36-S37
2 p.
 artikel
28 97 oral A novel beta particle silicon dosimeter 2004
 71 S2 p. S48-
1 p.
 artikel
29 8 oral A prostate phantom for quality control of MR and CT based postimplant seed reconstruction 2004
 71 S2 p. S4-
1 p.
 artikel
30 43 oral A retrospective comparison of the use of androgen deprivation among low and intermediate-risk prostate cancer patients treated with brachytherapy, external beam radiotherapy, or radical prostatectomy 2004
 71 S2 p. S21-
1 p.
 artikel
31 9 oral Assessment of prostate volume determining parameters in I-125 therapy 2004
 71 S2 p. S4-
1 p.
 artikel
32 13 oral A systematic quality control of seed dosimetry with an automatic needle loading system for permanent prostate implant 2004
 71 S2 p. S6-
1 p.
 artikel
33 11 oral Automatic seed localization, using MR images, for post implant assessment following prostate seed implantation 2004
 71 S2 p. S5-
1 p.
 artikel
34 67 oral Biologic image (MRSI) guided intraoperative computer optimized -directed dose escalation for transperineal permanent interstitial prostate implantation 2004
 71 S2 p. S34-
1 p.
 artikel
35 77 oral Brachytherapy for accelerated partial breast irradiation: factors affecting toxicity and cosmesis 2004
 71 S2 p. S38-S39
2 p.
 artikel
36 124 oral Brachytherapy for penile cancer: results for 49 patients 2004
 71 S2 p. S61-S62
2 p.
 artikel
37 93 oral Can we rely on source holder correction factors given by the well chamber vendor? 2004
 71 S2 p. S46-
1 p.
 artikel
38 104 oral Chronic toxicity profile and biochemical outcome in favorable-stage prostate cancer patients undergoing monotherapy with HDR or LDR (Pd103) brachytherapy at William Beaumont Hospital 2004
 71 S2 p. S52-
1 p.
 artikel
39 116 oral Combined external beam radiation therapy and HDR intracavitary brachytherapy boost in nasopharyngeal cancer: a retrospective analysis 2004
 71 S2 p. S58-
1 p.
 artikel
40 23 oral Combined MRI-based intracavitary and interstitial brachyterapy for locally advanced cervical cancer with a modified tandem ring applicator- clinical feasibility and preliminary results 2004
 71 S2 p. S10-S11
2 p.
 artikel
41 18 oral Comparison of twelve-year treatment results of advanced cervical carcinoma with Californium-252 vs. gamma radiation only in brachytherapy 2004
 71 S2 p. S8-
1 p.
 artikel
42 45 oral Comparison of two low dose rates in vaginal prophylactic pre-operative brachytherapy for patients with stage I-II endometrial carcinoma : long-term results of a randomised trial 2004
 71 S2 p. S22-
1 p.
 artikel
43 37 oral Comparison of 5-year outcomes between conformal LDR brachytherapy and high dose IMRT for patients with clinically localized prostate cancer 2004
 71 S2 p. S18-
1 p.
 artikel
44 107 oral Comprehensive quality of life comparison between high dose conformal radiotherapy and intraoperative-planned conformal brachytherapy for patients with localized prostate cancer 2004
 71 S2 p. S54-
1 p.
 artikel
45 54 oral Consequences of brachytherapy (BT) on uterine myocontractility 2004
 71 S2 p. S26-
1 p.
 artikel
46 52 oral Conservative treatment for vulvar cancer: chemoradiation and high dose rate brachytherapy 2004
 71 S2 p. S25-
1 p.
 artikel
47 111 oral Decreased incidence of urinary retention after prostate brachytherapy: the effect of learning curve? 2004
 71 S2 p. S55-S56
2 p.
 artikel
48 66 oral 3-dimensional MR spectroscopic imaging of prostate pre and post brachytherapy 2004
 71 S2 p. S34-
1 p.
 artikel
49 42 oral Dose escalation and toxicity limitation in prostate cancer therapy: conforming external beam treatment to dose delivered to prostate and critical adjacent normal structures by I-125 permanent implants 2004
 71 S2 p. S20-S21
2 p.
 artikel
50 22 oral Dose parameters for MRI based treatment planning — Analysis of 93 individual fractions in HDR cervix cancer brachytherapy for 22 patients 2004
 71 S2 p. S9-S10
2 p.
 artikel
51 79 oral Dose-volume evaluation of HDR interstitial breast implants planned by traditional and image-based dosimetry systems 2004
 71 S2 p. S39-S40
2 p.
 artikel
52 35 oral Early biochemical outcome following permanent interstitial brachytherapy as monotherapy in T1-T2 prostate cancer: results of a collaborative group on prostate brachytherapy 2004
 71 S2 p. S17-S18
2 p.
 artikel
53 109 oral Early urinary morbidity after I125 transperineal interstitial permanent prostate brachytherapy. A multivariate analysis of 600 patients treated by the Institut Curie / Hopital Cochin/Hopital Necker Paris group 2004
 71 S2 p. S54-S55
2 p.
 artikel
54 108 oral Effect of multiple variables on acute urinary morbidity following permanent I-125 implantation of the prostate: insights from a prospective, randomized trial 2004
 71 S2 p. S54-
1 p.
 artikel
55 126 oral Endovascular Brachytherapy with 192Iridium after Femoropopliteal-Stenting. Results from the Vienna-5 Trial 2004
 71 S2 p. S62-
1 p.
 artikel
56 112 oral Erectile dysfunction (ED) after prostate cancer brachytherapy as sole treatment modality. The William Beaumont Hospital's experience with HDR vs. LDR (Pd103 permanent implants) 2004
 71 S2 p. S56-
1 p.
 artikel
57 118 oral Exclusive LDR brachytherapy in 279 patients with T2N0 tongue carcinoma 2004
 71 S2 p. S59-
1 p.
 artikel
58 56 oral Factors influencing local failure and long-term outcomes among patients receiving high dose rate Iridium-192 intraoperative brachytherapy for colorectal adenocarcinoma 2004
 71 S2 p. S27-
1 p.
 artikel
59 71 oral Factors predicting for urinary incontinence following prostate brachytherapy 2004
 71 S2 p. S36-
1 p.
 artikel
60 122 oral First report of an institutional phase I-II trial of perioperative fractionated HDR brachytherapy (PHDRB) 2004
 71 S2 p. S60-S61
2 p.
 artikel
61 70 oral Genito-urinary and gastro-intestinal toxicity after inverse planned permanent prostate implant with high activity seeds 2004
 71 S2 p. S35-S36
2 p.
 artikel
62 125 oral Gliasite radiotherapy system for treatment of recurrent malignant glioma: a multi-institutional analysis 2004
 71 S2 p. S62-
1 p.
 artikel
63 17 oral High dose rate brachytherapy in the management of cervix cancer 2004
 71 S2 p. S7-S8
2 p.
 artikel
64 117 oral High dose rate brachytherapy with stiff applicators in the treatment of nasopharyngeal lymphoepithelioma in childhood 2004
 71 S2 p. S59-
1 p.
 artikel
65 121 oral High dose rate (HDR) interstitial brachytherapy for stage III and IV head and neck cancers 2004
 71 S2 p. S60-
1 p.
 artikel
66 21 oral Imaging the non-displaced rectosigmoid during HDR brachytherapy for cervical cancer can alter dose specification 2004
 71 S2 p. S9-
1 p.
 artikel
67 41 oral Impact of hormone therapy on post implant dosimetry and outcome following I-125 implant monotherapy for localised prostate cancer 2004
 71 S2 p. S20-
1 p.
 artikel
68 39 oral Improved biochemical relapse-free survival for patients with large/wide glands treated with prostate seed implantation for low and intermediate-risk adenocarcinoma of the prostate 2004
 71 S2 p. S19-
1 p.
 artikel
69 110 oral Influence of intraoperative prostate volume on early urinary toxicity after permanent prostate brachytherapy 2004
 71 S2 p. S55-
1 p.
 artikel
70 69 oral Influence of postoperative dosimetric parameters on acute and chronic toxicity following peripheral loading brachytherapy with stranded iodine seeds 2004
 71 S2 p. S35-
1 p.
 artikel
71 24 oral Initial clinical results of inverse planned high dose rate interstitial implants for cervical cancer 2004
 71 S2 p. S11-
1 p.
 artikel
72 25 oral Intercomparison of treatment concepts for 3D image guided brachytherapy of cervical carcinoma based on a GEC-ESTRO study protocol 2004
 71 S2 p. S11-S12
2 p.
 artikel
73 50 oral Intravaginal HDR brachytherapy alone for intermediate risk endometrioid adenocarcinoma of the uterus 2004
 71 S2 p. S24-
1 p.
 artikel
74 113 oral 125-Iodine prostate brachytherapy & erectile dysfunction-prospective UK data 2004
 71 S2 p. S56-
1 p.
 artikel
75 78 oral Is the breast post-operative seroma a reliable guide for planning accelerated partial breast irradiation? 2004
 71 S2 p. S39-
1 p.
 artikel
76 19 oral LDR interstitial brachytherapy in the management of carcinoma of the cervix 2004
 71 S2 p. S8-S9
2 p.
 artikel
77 53 oral Local control with interstitial brachytherapy implants in patients with carcinoma of the vagina 2004
 71 S2 p. S25-S26
2 p.
 artikel
78 34 oral Long term outcome following lodine-125 permanent seed implant for localised prostate cancer: Leeds experience 2004
 71 S2 p. S17-
1 p.
 artikel
79 14 oral Long-term results of a randomised trial comparing two preoperative low dose-rates brachytherapy in patients with cervix cancer 2004
 71 S2 p. S6-S7
2 p.
 artikel
80 119 oral Long time experience of pulsed brachytherapy in base of tongue cancers 2004
 71 S2 p. S59-S60
2 p.
 artikel
81 123 oral Low dose rate intraoperative brachytherapy in soft tissue sarcomas involving neurovascular structures 2004
 71 S2 p. S61-
1 p.
 artikel
82 95 oral On-line implant reconstruction in HDR brachytherapy 2004
 71 S2 p. S47-
1 p.
 artikel
83 106 oral Outcome and quality of life after HDR brachytherapy in patients with high-risk localized prostate cancer 2004
 71 S2 p. S53-
1 p.
 artikel
84 2 oral + poster Current status of brachytherapy facilities and applications in Poland 2004
 71 S2 p. S1-
1 p.
 artikel
85 3 oral + poster Patterns of care for brachytherapy in Europe (PCBE): results in Spain 2004
 71 S2 p. S1-S2
2 p.
 artikel
86 4 oral + poster Results of the PCBE questionnaire — 2002 in France 2004
 71 S2 p. S2-
1 p.
 artikel
87 5 oral + poster Results of the PCBE questionnaire-2002 in The Netherlands 2004
 71 S2 p. S2-S3
2 p.
 artikel
88 47 oral Post-operative external beam radiotherapy and vaginal cuff brachytherapy boost for endometrial cancer: survival rates, sites of failure and prognostic factors for recurrence 2004
 71 S2 p. S23-
1 p.
 artikel
89 68 oral Pre and post implant dosimetry for Iodine 125 prostate implant: comparison analysis 2004
 71 S2 p. S34-S35
2 p.
 artikel
90 51 oral Predictors of treatment outcome after low dose rate temporary interstitial implantation for patients with locally advanced gynaecologic malignancies 2004
 71 S2 p. S24-S25
2 p.
 artikel
91 120 oral Primary carcinoma of the oropharynx, relapse and complications: cost analysis comparing brachytherapy versus surgery 2004
 71 S2 p. S60-
1 p.
 artikel
92 48 oral Prognostic factors on adjuvant radiotherapy of endometrial carcinoma: experience with external beam radiotherapy and high-dose rate brachytherapy 2004
 71 S2 p. S23-
1 p.
 artikel
93 38 oral Prognostic significance of percent positive biopsies in clinically organ-confined prostate cancer treated with permanent prostate brachytherapy with or without supplemental external beam radiation 2004
 71 S2 p. S18-S19
2 p.
 artikel
94 46 oral Prophylactic vaginal high dose rate brachytherapy after pelvic irradiation in endometrial carcinoma 2004
 71 S2 p. S22-
1 p.
 artikel
95 103 oral Prostate brachytherapy toxicity: Leeds experience 2004
 71 S2 p. S52-
1 p.
 artikel
96 33 oral Prostate cancer patients treated with external beam radiation therapy combined with I125/Pd103 brachytherapy: Seattle's fifteen year outcome results 2004
 71 S2 p. S17-
1 p.
 artikel
97 36 oral Results of high dose rate (HDR) brachytherapy boost for prostate cancer 2004
 71 S2 p. S18-
1 p.
 artikel
98 15 oral Retrospectively analysis of 449 cervical cancers treated with high-voltage beam-irradiation (EBRT) and high-dose-rate afterloading (HDR) 2004
 71 S2 p. S7-
1 p.
 artikel
99 44 oral Salvage treatment in local relapses after permanent prostate brachytherapy 2004
 71 S2 p. S21-S22
2 p.
 artikel
100 75 oral Second conservative treatment for early breast cancer: a non-randomized comparison with mastectomy 2004
 71 S2 p. S38-
1 p.
 artikel
101 114 oral Sexual function after permanent implant brachytherapy for prostate cancer : a multivariate analysis 2004
 71 S2 p. S56-S57
2 p.
 artikel
102 55 oral Sphincter preservation and brachytherapy for cancer of the rectum: updated results on 52 patients 2004
 71 S2 p. S26-
1 p.
 artikel
103 20 oral Systematic evaluation of MRI and clinical findings in cervical cancer at diagnosis and at time of brachytherapy: potential of MRI on delineation of GTV, patho-anatomical structures and organs at risk 2004
 71 S2 p. S9-
1 p.
 artikel
104 40 oral The impact of supplemental external beam radiation and/or androgen deprivation therapy on biochemical outcome following permanent prostate brachytherapy 2004
 71 S2 p. S19-S20
2 p.
 artikel
105 73 oral TI breast cancer tumors: results of breast-conserving therapy 2004
 71 S2 p. S37-
1 p.
 artikel
106 10 oral Time-intregrated DVH for clinical post-implant dosimetric assessments in I-125 permanent prostate brachytherapy 2004
 71 S2 p. S4-S5
2 p.
 artikel
107 94 oral TLD dosimetry verification of dose optimisation method used in endovascular brachytherapy of peripheral vessels 2004
 71 S2 p. S47-
1 p.
 artikel
108 74 oral Toxicity, local control and cosmesis after interstitial partial breast HDR brachytherapy alone for T1/T2 breast cancer 2004
 71 S2 p. S37-S38
2 p.
 artikel
109 1 Patterns of care for brachytherapy in Europe (PCBE) 2004
 71 S2 p. S1-
1 p.
 artikel
110 99 PDR brachytherapy in carcinoma of cervix 2004
 71 S2 p. S49-S50
2 p.
 artikel
111 60 Permanent seed implantation: the proven choice for your patient 2004
 71 S2 p. S30-
1 p.
 artikel
112 28 Pitfalls in the use of TG-43 in brachytherapy treatment planning, some examples 2004
 71 S2 p. S14-
1 p.
 artikel
113 133 poster Accelerated partial breast irradiation (APBI): are the current dose prescriptions for brachytherapy and 3D conformal external beam (3D-CRT) equivalent? 2004
 71 S2 p. S65-S66
2 p.
 artikel
114 288 poster A comparison of permanent brachytherapy (BT) and 3D conformal radiation therapy (3DCRT) for localized prostate cancer 2004
 71 S2 p. S124-
1 p.
 artikel
115 233 poster A comparison of seed coordinates between CT based postplanning and a software based guidance system for intraoperative dosimetry during prostate seed implants 2004
 71 S2 p. S103-
1 p.
 artikel
116 313 poster Adjuvant High Dose Rate brachytherapy alone or combined with external beam radiation in endometrial cancer 2004
 71 S2 p. S133-S134
2 p.
 artikel
117 321 poster Adjuvant intravaginal high dose rate brachytherapy in endometrial adenocarcinoma 2004
 71 S2 p. S136-S137
2 p.
 artikel
118 185 poster A fractionated brachytherapy mold technique can replace IMRT for treatment of a complex shallow target 2004
 71 S2 p. S85-
1 p.
 artikel
119 285 poster A MRI based treatment concept for interstitial HDR prostate treatments — Part I: clinical feasibility 2004
 71 S2 p. S122-S123
2 p.
 artikel
120 273 poster A MRI based treatment planning concept for interstitial HDR prostate treatments — Part II: dose and volume parameters 2004
 71 S2 p. S118-S119
2 p.
 artikel
121 235 poster Anatomy-based inverse planning dose optimization for HDR prostate implant boost: a toxicity report 2004
 71 S2 p. S104-
1 p.
 artikel
122 295 poster Androgen deprivation-induced changes in prostate anatomy predict urinary morbidity following permanent interstitial brachytherapy 2004
 71 S2 p. S127-
1 p.
 artikel
123 261 poster Androgendeprivation therapy in the management of patients with prostate volumes too large for radioactive seed implantation 2004
 71 S2 p. S113-S114
2 p.
 artikel
124 203 poster A newly available radio-isotope with dosimetric and biologic advantages for the treatment of prostate cancer 2004
 71 S2 p. S91-S92
2 p.
 artikel
125 139 poster A new methodology for quantitatively measuring conformance index of mammosite catheter implants 2004
 71 S2 p. S68-
1 p.
 artikel
126 155 poster Anxiety and depression in gynaecologic cancer patients before, during and after brachytherapy. a randomized study 2004
 71 S2 p. S74-
1 p.
 artikel
127 132 poster A phase II randomised trial of partial breast irradiation for early stage breast cancer using the mammosite® radiation therapy system vs. conventional external beam radiotherapy (EBRT) 2004
 71 S2 p. S65-
1 p.
 artikel
128 166 poster A pilot phase II trial with Cisplatin — Paclitaxel treatment and concurrent external and endocavitary radiotherapy in locally advanced cervical cancer 2004
 71 S2 p. S78-
1 p.
 artikel
129 181 poster Application of the TG-43 dosimetry protocol to electronic brachytherapy sources 2004
 71 S2 p. S84-
1 p.
 artikel
130 323 poster A radiobiological model for the relative biological effectiveness of high dose rate Cf-252 brachytherapy 2004
 71 S2 p. S137-
1 p.
 artikel
131 320 poster A review of clinical application using Californium-252 2004
 71 S2 p. S136-
1 p.
 artikel
132 153 poster A simple method to minimize critical structure irradiation based on analysis of inter-fractional geometric variation in the course of vaginal cuff brachytherapy 2004
 71 S2 p. S73-S74
2 p.
 artikel
133 227 poster Assessment of pain and its contributing factors during HDR prostate brachytherapy 2004
 71 S2 p. S101-
1 p.
 artikel
134 272 poster Biochemical control and tolerance of HDR brachytherapy and 3-dimensional conformal radiotherapy for patients with clinically localized prostate cancer 2004
 71 S2 p. S118-
1 p.
 artikel
135 186 poster Bouquet brachytherapy: the feasibility and optimization of conically spaced implants 2004
 71 S2 p. S85-S86
2 p.
 artikel
136 329 poster Brachynet — A brachytherapy database and information management system 2004
 71 S2 p. S139-
1 p.
 artikel
137 199 poster Brachytherapy in confined prostate cancer treated with I 125, experience in Mexico 2004
 71 S2 p. S90-
1 p.
 artikel
138 168 poster Brachytherapy of adenocarcinoma of cervix uteri and endometrial adenocarcinoma 2004
 71 S2 p. S79-
1 p.
 artikel
139 246 poster Brachytherapy of prostate cancer in patients with prior colorectal cancer 2004
 71 S2 p. S108-
1 p.
 artikel
140 169 poster Brachytherapy of the uterine cervix using 60Co-HDR and 137Cs-MDR 2004
 71 S2 p. S79-
1 p.
 artikel
141 292 poster Can we accrue to “difficult” trials in brachytherapy? 2004
 71 S2 p. S126-
1 p.
 artikel
142 301 poster Carcinoma of the oral tongue T1-t2 with positive margins. Postoperative brachytherapy 2004
 71 S2 p. S129-
1 p.
 artikel
143 167 poster Carcinoma of the uterine cervix: a single institution experience using PDR brachytherapy in 125 consecutive patients 2004
 71 S2 p. S78-S79
2 p.
 artikel
144 146 poster Carcinoma of the uterine cervix: moving from LDR to HDR 2004
 71 S2 p. S70-
1 p.
 artikel
145 232 poster Catheter reconstruction in TRUS-guided interstitial prostate HDR-brachytherapy under realtime-guidance with the planning system “Swift” 2004
 71 S2 p. S103-
1 p.
 artikel
146 282 poster Chronic fatigue after permanent interstitial I-125-brachytherapy, temporary interstitial Ir-192-brachytherapy and external beam radiotherapy for prostate cancer 2004
 71 S2 p. S122-
1 p.
 artikel
147 267 poster Clinical benefits of a class solution for inversely planned HDR prostate brachytherapy 2004
 71 S2 p. S116-
1 p.
 artikel
148 217 poster Clinical outcome of patients with prostate cancer treated with external beam radiation and iridium sources 2004
 71 S2 p. S97-
1 p.
 artikel
149 243 poster Combination of High Dose Rate brachytherapy boost and adjuvant hormonal therapy for prostate cancer 2004
 71 S2 p. S107-
1 p.
 artikel
150 239 poster Combined 3-dimensional conformal radiotherapy and interstitial permanent implant for patients with intermediate and unfavourable risk prostate cancer 2004
 71 S2 p. S105-S106
2 p.
 artikel
151 151 poster Combined MRI based intracavitary and interstitial brachytherapy for locally advanced cervical cancer with a modified tandem ring applicator — Design, quality assurance and dosimetry 2004
 71 S2 p. S72-S73
2 p.
 artikel
152 258 poster Combined surgery and brachytherapy for lymph node negative bladder carcinoma 2004
 71 S2 p. S112-
1 p.
 artikel
153 222 poster Combined ultrasound-radiographic approach to the intraoperative detection of seeds in prostate brachytherapy: a feasibility study 2004
 71 S2 p. S99-S100
2 p.
 artikel
154 204 poster Comparison of CT and ultrasound based treatment planning for treatment of prostate gland using high dose rate (HDR) brachytherapy 2004
 71 S2 p. S92-
1 p.
 artikel
155 212 poster Comparison of dose distribution at the intraprostatic urethra based on interactive dynamic real-time TRUS and CT after permanent seed implantation 2004
 71 S2 p. S95-
1 p.
 artikel
156 147 poster Comparison of dose volume histograms of 3-d brachytherapy planning for cervical cancer with empty and full bladder 2004
 71 S2 p. S70-S71
2 p.
 artikel
157 260 poster Comparison of perioperative morbidity and acute toxicity in prostate HDR brachytherapy with permanent seed implants 2004
 71 S2 p. S113-
1 p.
 artikel
158 290 poster Comparison of race and prostate cancer outcome in patients treated with brachytherapy 2004
 71 S2 p. S125-
1 p.
 artikel
159 331 poster Comparison of results with external beam irradiation (EBI) or EBI + interstitial high dose rate (HDR) brachytherapy (BT) in the treatment of base of tongue tumors 2004
 71 S2 p. S140-
1 p.
 artikel
160 224 poster Comparison of virtual and live plans in -real time-brachytherapy inprostate cancer based on ultrasound examination 2004
 71 S2 p. S100-
1 p.
 artikel
161 138 poster Conformal peroperative interstitial sole brachytherapy of early stage breast carcinoma using the HDR afterloading 2004
 71 S2 p. S67-
1 p.
 artikel
162 201 poster Conformance of the seedselectron to manufacturer specifications and ABS/AAPM recommendations 2004
 71 S2 p. S91-
1 p.
 artikel
163 225 poster Conformity error: a new method for evaluating the conformity of interstitial brachytherapy implants 2004
 71 S2 p. S100-S101
2 p.
 artikel
164 322 poster Conservative treatment of intra-ocular melanoma with Iodine-125 brachytherapy 2004
 71 S2 p. S137-
1 p.
 artikel
165 252 poster Coverage of extra-capsular extension (ECE) with three dimensional conformal external beam radiotherapy (3DCRT) or permanent prostate seed implantation (PPI) 2004
 71 S2 p. S110-S111
2 p.
 artikel
166 165 poster CT based dose distribution and optimization for gynaecological pulsed dose rate interstitial brachytherapy 2004
 71 S2 p. S78-
1 p.
 artikel
167 142 poster CT-based treatment planning in mammosite brachytherapy 2004
 71 S2 p. S69-
1 p.
 artikel
168 144 poster CT computer-optimized HDR surface applicator brachytherapy provides a more homogeneous scar boost dose than electrons following breast reconstruction 2004
 71 S2 p. S69-S70
2 p.
 artikel
169 316 poster CT images versus simulator images for dose planning of head & neck tumours 2004
 71 S2 p. S135-
1 p.
 artikel
170 294 poster CT, MRI, and CT-MRI image fusion assessment for prostate I-125 post implant dosimetry 2004
 71 S2 p. S126-S127
2 p.
 artikel
171 229 poster Deciding on a treatment for prostate cancer: how and why menchoose high dose rate (HDR) brachytherapy 2004
 71 S2 p. S102-
1 p.
 artikel
172 247 poster Detection of local recurrence after J-125 permanent brachytherapy of the prostate by 11C-Cholin-PET-CT and consequences for therapy 2004
 71 S2 p. S108-S109
2 p.
 artikel
173 176 poster Development of a field-customizable neural network nomogram equivalent 2004
 71 S2 p. S82-
1 p.
 artikel
174 87 poster dis Acute urinary retention following magnetic-resonance-image-guided prostate brachytherapy 2004
 71 S2 p. S43-S44
2 p.
 artikel
175 86 poster dis A prospective study of PSA bounce following Iodine-125 brachytherapy in low risk prostate cancer 2004
 71 S2 p. S43-
1 p.
 artikel
176 81 poster dis Design of a web page with the dosimetric parameters for all the different models of Cs-137 and Ir-192 sources used in brachytherapy 2004
 71 S2 p. S41-
1 p.
 artikel
177 80 poster dis Dosimetric comparisons between MammoSite HDR brachytherapy and conventional electron boost after external beam radiotherapyfor early-stage breast cancer 2004
 71 S2 p. S41-
1 p.
 artikel
178 82 poster dis Individualized vaginal moulds for LDR Iridium-192. Results in 55 patients 2004
 71 S2 p. S41-S42
2 p.
 artikel
179 88 poster dis Influence of source strength on outcomes in patients undergoing prostate I-125 seed implants for prostate carcinoma 2004
 71 S2 p. S44-
1 p.
 artikel
180 91 poster dis Intraoperative real-time planning for HDR brachytherapy as monotherapy in early stage prostate cancer 2004
 71 S2 p. S45-
1 p.
 artikel
181 89 poster dis Iodine-125 prostate brachytherapy in localized prostate cancer: importance of team experience for dose delivery ad toxicity 2004
 71 S2 p. S44-S45
2 p.
 artikel
182 85 poster dis PSA results after Iodine seed prostate brachytherapy in the UK with up to five years follow up 2004
 71 S2 p. S43-
1 p.
 artikel
183 83 poster dis Pulsed dose rate (PDR) intraoperative brachytherapy in soft tissue sarcomas : a retrospective study of 30 patients 2004
 71 S2 p. S42-
1 p.
 artikel
184 84 poster dis Squamous cell carcinoma of the lip and interstitial low dose rate brachytherapy (LDR). Evaluation of prognostic factors and estetic results 2004
 71 S2 p. S42-S43
2 p.
 artikel
185 90 poster dis Use of magnetic resonance imaging and spectroscopy to compare the metabolic response of the prostate following external beam radiation therapy and permanent prostate implants for early stage prostate cancer 2004
 71 S2 p. S45-
1 p.
 artikel
186 245 poster Does anaesthesia method impact implant-induced swelling of the prostate? 2004
 71 S2 p. S108-
1 p.
 artikel
187 257 poster Does cigarette smoking influence biochemical outcome following permanent prostate brachytherapy? 2004
 71 S2 p. S112-
1 p.
 artikel
188 269 poster Dose-effect relationship for grade-2 urethral toxicity in permanent prostate implants 2004
 71 S2 p. S117-
1 p.
 artikel
189 297 poster Dose escalation by HDR brachytherapy in intermediate or high risk localized prostate cancer: early toxicity and biochemical outcome of a pilot study 2004
 71 S2 p. S128-
1 p.
 artikel
190 183 poster Dose response of gafchromic XR-T film to a new electronic brachytherapy source 2004
 71 S2 p. S84-S85
2 p.
 artikel
191 283 poster Dose-volume-time-impact on toxicity in interstitial temporary HDR-Ir-192-brachytherapy (BT) for prostate cancer 2004
 71 S2 p. S122-
1 p.
 artikel
192 182 poster Dosimetric study of the 15 mm ropes eye plaque 2004
 71 S2 p. S84-
1 p.
 artikel
193 244 poster Dosimetry of high dose rate (HDR) brachytherapy is highly reliable 2004
 71 S2 p. S107-S108
2 p.
 artikel
194 305 poster Early stage carcinomas of the mobile tongue: influence of modality treatment (curietherapy versus external irradiation combined with curietherapy) on local control and survival 2004
 71 S2 p. S131-
1 p.
 artikel
195 326 poster Effect and toxicity of palliative HDR and PDR brachytherapy in patients with recurrent head and neck cancer 2004
 71 S2 p. S138-
1 p.
 artikel
196 310 poster Effects of interstitial PDR and CLDR brachytherapy on cell cycle progression in a syngeneic rat prostate tumor model 2004
 71 S2 p. S132-S133
2 p.
 artikel
197 208 poster Efficiency of manual and automatic seed delivery in permanent prostate implants 2004
 71 S2 p. S93-
1 p.
 artikel
198 140 poster Electronic (non-isotopic) high dose rate brachytherapy (EHDRB): design, characterization and pilot animal trial of a novel method of accelerated partial breast irradiation 2004
 71 S2 p. S68-
1 p.
 artikel
199 194 poster Enzymatic prostatic acid phosphatase in the clinical staging of patients with newly diagnosed, untreated prostate cancer 2004
 71 S2 p. S88-S89
2 p.
 artikel
200 172 poster Evaluation of technical failures during treatment in pulsed dose rate brachytherapy 2004
 71 S2 p. S80-S81
2 p.
 artikel
201 191 poster Experience associated with the verification of the reference air kerma rate of I-125 seeds 2004
 71 S2 p. S87-S88
2 p.
 artikel
202 154 poster Experience with high-dose-rate brachytherapy (HDR) in carcinoma uterine cervix in the department of Radiation Oncology of Hospital Carlos Haya in Malaga (Spain) 2004
 71 S2 p. S74-
1 p.
 artikel
203 240 poster Extending protection of organ at risk to the bulb of the penis yields conformal treatment plans and lower D70% and D50% bulb doses with inverse planned simulated annealing (IPSA) high dose rate (HDR) brachytherapy 2004
 71 S2 p. S106-
1 p.
 artikel
204 205 poster Factors predicting an increased dose to the penile bulb in permanent seed prostate brachytherapy 2004
 71 S2 p. S92-
1 p.
 artikel
205 231 poster First experiences with dynamic interactive realtime dose verification during transperineal permanent seed implantation (TPSI) of patients with “low risk” prostate cancer in an outpatient setting 2004
 71 S2 p. S102-S103
2 p.
 artikel
206 215 poster First results of brachytherapy for prostate cancer with J-125-seeds using the nucletron first™ system 2004
 71 S2 p. S96-
1 p.
 artikel
207 162 poster First results of chemoradiation in cervical cancers with high dose rate brachytherapy combined with external beam radiotherapy 2004
 71 S2 p. S76-S77
2 p.
 artikel
208 263 poster HDR-afterloading in locally advanced prostate cancer in an outpatient setting — experience of an interdisciplinary prostate center 2004
 71 S2 p. S114-
1 p.
 artikel
209 318 poster HDR and LDR brachytherapy in the treatment of paediatric tumours. A single institution experience on 21 patients 2004
 71 S2 p. S135-S136
2 p.
 artikel
210 210 poster HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation for unfavourable stage prostate cancer 2004
 71 S2 p. S94-
1 p.
 artikel
211 128 poster HDR/PDR interstitial intensity modulated brachytherapy for local recurrences of the breast/thoracic wall following breast cancer 2004
 71 S2 p. S63-
1 p.
 artikel
212 279 poster Health related quality of life in low to high-risk prostate cancer patients treaded by brachytherapy and 3D conformal radiotherapy 2004
 71 S2 p. S121-
1 p.
 artikel
213 312 poster High dose rate brachytherapy as conservative treatment for vulvar cancer 2004
 71 S2 p. S133-
1 p.
 artikel
214 141 poster High dose rate brachytherapy boost in breast-conserving surgery: skin-sparing and target determination 2004
 71 S2 p. S68-
1 p.
 artikel
215 299 poster High dose rate brachytherapy (HDR) in endometrium carcinoma. Carlos Haya Hospital Experience in Malaga (Spain) 2004
 71 S2 p. S128-S129
2 p.
 artikel
216 131 poster High dose rate brachytherapy in conservative treatment of breast cancer. An ambulatory method. Analysis of results 2004
 71 S2 p. S64-S65
2 p.
 artikel
217 327 poster High dose rate endobronchial brachytherapy in the management of advanced lung cancer — Comparison of different protocols 2004
 71 S2 p. S138-S139
2 p.
 artikel
218 306 poster High dose rate (HDR) brachytherapy treatment for skin cancer 2004
 71 S2 p. S131-
1 p.
 artikel
219 148 poster High (HDR) and low dose rates (LDR) brachytherapy (BT): comparison of side-effects and survival 2004
 71 S2 p. S71-
1 p.
 artikel
220 287 poster I-125 isodose patterns as predictors of inadequate prostate brachytherapy dose coverage 2004
 71 S2 p. S123-S124
2 p.
 artikel
221 242 poster Image-fusion based CT pre and post-implant in seed implantation: a useful tool for accurate prostate definition in the post-planning setting 2004
 71 S2 p. S107-
1 p.
 artikel
222 315 poster Image fusion of CT and MRI data enables improved target volume definition in 3d-brachytherapy treatment planning 2004
 71 S2 p. S134-
1 p.
 artikel
223 266 poster Improved dosimetry by the use of a unique interactive image registered intra- operative treatment planning system for permanent seed brachytherapy 2004
 71 S2 p. S115-S116
2 p.
 artikel
224 220 poster Improved patient education for prostate brachytherapy using web-based paling diagrams for graphical representation of data 2004
 71 S2 p. S98-S99
2 p.
 artikel
225 157 poster Increasing the dose rate of medium dose rate brachytherapy in the definitive radiation treatment of advanced cervical carcinoma: impact on local control and late complications 2004
 71 S2 p. S75-
1 p.
 artikel
226 197 poster Intermediate results of ferromagnetic thermal ablation for radiation failure local recurrence of prostate cancer 2004
 71 S2 p. S89-S90
2 p.
 artikel
227 150 poster Interstitial brachytherapy (MUPIT) in gynaecologic tumors: results and toxicity analysis 2004
 71 S2 p. S72-
1 p.
 artikel
228 302 poster Interstitial HDR-brachytherapy in patients with oral cavity and oropharyngeal cancer -treatment results and complications based upon material of Institute of Oncology in Gliwice 2004
 71 S2 p. S129-S130
2 p.
 artikel
229 328 poster Intraluminal pulsed dose rate (PDR) brachytherapy for locally advanced bile ducts cancer: a case report 2004
 71 S2 p. S139-
1 p.
 artikel
230 223 poster Intraoperative brachytherapy technique of low dose rate with 125I in real time and by dynamic calculation 2004
 71 S2 p. S100-
1 p.
 artikel
231 253 poster Introduction of the seed selectron for automatic seed delivery in permanent prostate implants 2004
 71 S2 p. S111-
1 p.
 artikel
232 226 poster Iodine 125 brachytherapy for prostate cancer in Ravenna (Italy) 2004
 71 S2 p. S101-
1 p.
 artikel
233 268 poster 125 I RAPIDStrand transperineal TRUS-guided prostate brachytherapy: A prospective comparison of low versus high activity sources 2004
 71 S2 p. S116-S117
2 p.
 artikel
234 293 poster I125 re-implantation in patients with poor initial dosimetry after prostate brachytherapy 2004
 71 S2 p. S126-
1 p.
 artikel
235 289 poster 192Ir LDR Brachytherapy(BT) is at least as efficient as HDR options for boosting intermediate or unfavourable prostate cancers after EBRT. Experience on 201 patients 2004
 71 S2 p. S124-S125
2 p.
 artikel
236 130 poster Long-term results of chest wall reirradiation using pulsed dose rate (PDR) brachytherapy moulds for breast cancer local recurrences 2004
 71 S2 p. S64-
1 p.
 artikel
237 156 poster Magnetic resonance evaluation based mdifications of standard brachytherapy technique in cervical cancer treatment 2004
 71 S2 p. S75-
1 p.
 artikel
238 206 poster Measurement of urethral dose profiles in prostate brachytherapy using a linear Mosfet array dosimeter 2004
 71 S2 p. S92-S93
2 p.
 artikel
239 324 poster MEDARPA —Implantation of brachytherapy-catheters using augmented reality 2004
 71 S2 p. S137-
1 p.
 artikel
240 159 poster Medium and high dose rate brachytherapy for cervix cancer : experience of study group — Brazilian institutions 2004
 71 S2 p. S76-
1 p.
 artikel
241 274 poster Minimal displacement of self-anchoring brachytherapy catheters in temporary prostate implants 2004
 71 S2 p. S119-
1 p.
 artikel
242 214 poster Mixed stranded & free I-125 sources for permanent prostate implant 2004
 71 S2 p. S95-S96
2 p.
 artikel
243 149 poster MRI based treatment planning in cervical cancer brachytherapy : characteristics of the 2 cm3 volume receiving the highest dose in bladder and rectum walls, compared with ICRU reference points 2004
 71 S2 p. S71-S72
2 p.
 artikel
244 219 poster MRI-Guided HDR prostate brachytherapy in a Standard 1.5T Scanner 2004
 71 S2 p. S98-
1 p.
 artikel
245 152 poster MRI-guided treatment planning for cervical cancer patients treated with a combination of external beam radiotherapy and PDR-brachytherapy 2004
 71 S2 p. S73-
1 p.
 artikel
246 298 poster Multi phase radical treatment of anal cancer using concurrent chemo radiation and interstitial brachytherapy boost- Clatterbridge experience 2004
 71 S2 p. S128-
1 p.
 artikel
247 325 poster Neutron brachytherapy with Cf-252 low-dose-rate and concurrent chemotherapy in the treatment of primary cancer of the oral cavity 2004
 71 S2 p. S138-
1 p.
 artikel
248 271 poster Number of catheters in prostate high dose rate brachytherapy: the role of inverse planning 2004
 71 S2 p. S117-S118
2 p.
 artikel
249 330 poster Oesophageal fistula formation following oesophageal wall resection and permanent radioactive seed implantation for mediastinal carcinoid tumors 2004
 71 S2 p. S139-S140
2 p.
 artikel
250 158 poster One or two MDR-brachytherapy fractions inthe treatment of locally advanced cervical carcinoma 2004
 71 S2 p. S75-
1 p.
 artikel
251 286 poster Organ contouring in permanent prostate brachytherapy (PPB) post-implant evaluation: a multicentric study 2004
 71 S2 p. S123-
1 p.
 artikel
252 134 poster Partial breast brachytherapy using multiple dwell positions in a single channel interstitial device — mammosite 2004
 71 S2 p. S66-
1 p.
 artikel
253 135 poster Partial breast high dose rate (HDR) brachytherapy: a preliminary prospective study 2004
 71 S2 p. S66-
1 p.
 artikel
254 143 poster Partial breast irradiation using mammosite RTS: preliminary results of a single institution phase II pilot study 2004
 71 S2 p. S69-
1 p.
 artikel
255 190 poster 32P endovascular brachytherapy source experimental dosimetry 2004
 71 S2 p. S87-
1 p.
 artikel
256 177 poster Percent depth dose for a sphere of 32p chromic phosphorous colloid 2004
 71 S2 p. S82-
1 p.
 artikel
257 270 poster Permanent interstitial brachytherapy for clinically organ-confined high-grade prostate cancer with a pretreatment PSA 20 ng/ml 2004
 71 S2 p. S117-
1 p.
 artikel
258 296 poster Permanent interstitial brachytherapy for younger patients with clinically organ-confined prostate cancer 2004
 71 S2 p. S127-S128
2 p.
 artikel
259 198 poster Permanent I-125 prostatic seed implantation technique in a University Hospital. Preliminary results 2004
 71 S2 p. S90-
1 p.
 artikel
260 228 poster Permanent J-125 brachytherapy of localized prostate cancer — Quality of life and local control 2004
 71 S2 p. S101-S102
2 p.
 artikel
261 250 poster Permanent prostate brachytherapy as a second curative treatment in patients with local recurrences following external irradiation 2004
 71 S2 p. S110-
1 p.
 artikel
262 248 poster Permanent prostate gland seed implant: a comparison of dosimetry outcome between loose-seeds and rapid strand brachytherapy techniques 2004
 71 S2 p. S109-
1 p.
 artikel
263 304 poster Permanent prostate implants: information guide for patient and relatives 2004
 71 S2 p. S130-
1 p.
 artikel
264 291 poster Permanent prostate implant using high activity seeds and inverse planning with fast simulated annealing algorithm: an early Canadian experience 2004
 71 S2 p. S125-S126
2 p.
 artikel
265 173 poster Phantom size in brachytherapy source dosimetric studies 2004
 71 S2 p. S81-
1 p.
 artikel
266 163 poster Positional stability of Töre's applicator and dose variations with time during LDR brachytherapy for cervical carcinoma 2004
 71 S2 p. S77-
1 p.
 artikel
267 174 poster Practising the LD dosimetry concept for permanent prostatic seed implants 2004
 71 S2 p. S81-
1 p.
 artikel
268 136 poster Preliminary results of Pulsed Dose Rate peri-operative Brachytherapy (PDR BT) as an interstitial boost in conservative treatment (BCT) of breast cancer 2004
 71 S2 p. S66-S67
2 p.
 artikel
269 161 poster Preoperative concurrent radiotherapy and chemotherapy in uterine cervix cancer 2004
 71 S2 p. S76-
1 p.
 artikel
270 216 poster Prevention of prostate HDR needle dislocation using the brachybench, a secure, comfortable, “air-ride”, patient positioning and transfer device 2004
 71 S2 p. S96-
1 p.
 artikel
271 145 poster Prognostic factor analysis in primary radiotherapy of cervical carcinoma 2004
 71 S2 p. S70-
1 p.
 artikel
272 251 poster Prospective evaluation of urinary morbidity following permanent interstitial brachytherapy for localized prostate cancer 2004
 71 S2 p. S110-
1 p.
 artikel
273 218 poster Prostate brachytherapy with 125 I. Results of 45 patients treated at the Hospital de la Santa Creu i Sant Pau. Can dosimetric parameters predict the clinical outcome? 2004
 71 S2 p. S97-S98
2 p.
 artikel
274 202 poster Prostate HDR brachytherapy. An outpatient approach 2004
 71 S2 p. S91-
1 p.
 artikel
275 311 poster Prostate specific antigen bounce after hormonal ablation, external beam radiation therapy and high dose rate brachytherapy in the treatment of prostate cancer 2004
 71 S2 p. S133-
1 p.
 artikel
276 179 poster Protecting the urethra in prostate HDR brachytherapy: the template geometry does matter 2004
 71 S2 p. S83-
1 p.
 artikel
277 200 poster PSA bounce after transperineal iodine prostate brachytherapy 2004
 71 S2 p. S91-
1 p.
 artikel
278 319 poster Pulsed dose-brachytherapy of oropharyngeal carcinomas 2004
 71 S2 p. S136-
1 p.
 artikel
279 241 poster Quality assurance for fractionated high dose rate afterloading brachytherapy as monotherapy for prostate cancer 2004
 71 S2 p. S106-S107
2 p.
 artikel
280 249 poster Quality assurance in HDR brachytherapy for prostate cancer: how can prostate displacement be minimized? 2004
 71 S2 p. S109-
1 p.
 artikel
281 188 poster Quality assurance of a high dose rate afterloader 2004
 71 S2 p. S86-
1 p.
 artikel
282 187 poster Quality Assurance of Treament Planning System (TPS) in Low Dose Rate Brachytherapy (LDR) using Thermoluminescence Dosimetry (LiF) 2004
 71 S2 p. S86-
1 p.
 artikel
283 262 poster Quality of dose distribution with realtime-plan-modification (RPM) in permanent seed implants 2004
 71 S2 p. S114-
1 p.
 artikel
284 264 poster Quality of implant dosimetry for intraoperative versus preoperative planning for permanent prostate seed implants: are there differences in coverage of the base, mid-zone and apex of the prostate? 2004
 71 S2 p. S114-S115
2 p.
 artikel
285 276 poster Quality of life after prostate brachytherapy: a prospective study 2004
 71 S2 p. S120-
1 p.
 artikel
286 178 poster Radiation safety after permanent prostate brachyterapy 2004
 71 S2 p. S83-
1 p.
 artikel
287 280 poster 1251 RAPIDStrand versus 103Pd for localized prostate cancer: A dosimetric analysis 2004
 71 S2 p. S121-
1 p.
 artikel
288 314 poster Real-time intraoperative orientation for interstitial brachytherapy needle implantation using augmented reality 2004
 71 S2 p. S134-
1 p.
 artikel
289 213 poster Real time prostate implant with rapid strand I125 seeds. the experience with 43 patients treated in 2003 2004
 71 S2 p. S95-
1 p.
 artikel
290 254 poster Reliability of CT-based postimplant dose values in interstitial permanent brachytherapy 2004
 71 S2 p. S111-
1 p.
 artikel
291 164 poster Remote afterloading for HDR neutron brachytherapy with Californium-252 2004
 71 S2 p. S77-S78
2 p.
 artikel
292 160 poster Results of cervical carcinoma treated with external Radiotherapy and High Dose Rate Brachytherapy 2004
 71 S2 p. S76-
1 p.
 artikel
293 255 poster Salvage combined intensity modulated HDR brachytherapy and external beam treatment (EBRT) for local recurrences after radical prostatectomy: first results of a prospective feasibility & dose escalation study 2004
 71 S2 p. S111-S112
2 p.
 artikel
294 180 poster Silicon detector versus gafchromic film for brachytherapy sources characterisation 2004
 71 S2 p. S83-S84
2 p.
 artikel
295 196 poster Simplified data analysis with a relational database dedicated to prostate brachytherapy 2004
 71 S2 p. S89-
1 p.
 artikel
296 137 poster Single fraction boost with high dose rate brachytherapy in breast conserving therapy 2004
 71 S2 p. S67-
1 p.
 artikel
297 129 poster Skin ellipse technique for mammosite® device placement 2004
 71 S2 p. S64-
1 p.
 artikel
298 278 poster Targeting dominant intraprostatic lesion using functional imaging with MR spectroscopy and high dose rate brachytherapy 2004
 71 S2 p. S120-S121
2 p.
 artikel
299 281 poster Temporal effect of neoadjuvant androgen deprivation therapy on PSA kinetics following permanent prostate brachytherapy with or without supplemental external beam radiation 2004
 71 S2 p. S121-S122
2 p.
 artikel
300 184 poster The angular homogeneity index, a tool for greater precision and accuracy in the assessment of homogeneity 2004
 71 S2 p. S85-
1 p.
 artikel
301 236 poster The applicability of simultaneous CT-US imaging for the evaluation of prostate implants 2004
 71 S2 p. S104-S105
2 p.
 artikel
302 175 poster The BCCA's HDR breast brachytherapy program — A physicist's view 2004
 71 S2 p. S81-S82
2 p.
 artikel
303 207 poster The benefits provided by using intra-operative dosimetry and the fusion of MRI to CT for post plan dosimetry in the learning curve of transperineal interstitial permanent prostate brachytherapy 2004
 71 S2 p. S93-
1 p.
 artikel
304 193 poster The correlation between D90 and outcome for I-125 seed implant monotherapy for localised prostate cancer 2004
 71 S2 p. S88-
1 p.
 artikel
305 127 poster The dose volume relationship of lung and cardiac tissue in single source breast brachytherapy compared to external beam tangent fields for subclinical physiologic changes 2004
 71 S2 p. S63-
1 p.
 artikel
306 259 poster The impact of anatomic challenges on HDR dosimetry and implant toxicity 2004
 71 S2 p. S113-
1 p.
 artikel
307 211 poster The impact of intra-operative delivery accuracy on intra-operative and post-operative dosimetry for prostate treatments using a low dose-rate iodine-125 remote afterloader 2004
 71 S2 p. S94-S95
2 p.
 artikel
308 189 poster The impact of number of the Norman Simon (NS) applicators on dose distribution in endometrial cancer patients treated with pulsed dose rate brachytherapy (PDR BT) 2004
 71 S2 p. S86-S87
2 p.
 artikel
309 195 poster The impact of prostate volume and neoadjuvant androgen deprivation therapy on urinary function following prostate brachytherapy 2004
 71 S2 p. S89-
1 p.
 artikel
310 265 poster The influence of low dose regions on D90 values in permanent prostate implants 2004
 71 S2 p. S115-
1 p.
 artikel
311 300 poster The intracoronary brachytherapy for in-stent restenosis: clinical and film dosimetric results 2004
 71 S2 p. S129-
1 p.
 artikel
312 309 poster The role of external beam radiotherapy and brachytherapy in the treatment of bile duct and gall bladder tumors 2004
 71 S2 p. S132-
1 p.
 artikel
313 307 poster The role of high dose rate endobronchial brachytherapy in the palliation of patients with non-small cell lung cancer: a practice-guideline 2004
 71 S2 p. S131-S132
2 p.
 artikel
314 317 poster The role of high dose rate (HDR) brachytherapy in the management of soft tissue sarcomas 2004
 71 S2 p. S135-
1 p.
 artikel
315 277 poster The role of prophylactic tamsulosin(Flomax®) ± dexamethasone in patients undergoing prostate 125I seed implants for prostate carcinoma. A randomized double blind study 2004
 71 S2 p. S120-
1 p.
 artikel
316 209 poster The use of fiducial markers for verification of catheter position in HDR prostate brachytherapy 2004
 71 S2 p. S93-S94
2 p.
 artikel
317 192 poster Three dimensional dose distribution in pulsed dose rate oropharyngeal brachytherapy : comparison of 3 methods : non optimization, dose point optimization and inverse optimization 2004
 71 S2 p. S88-
1 p.
 artikel
318 303 poster Three dimension conformal brachytherapy for medically inoperable endometrial carcinomas helps to define small bowel risk of toxicity 2004
 71 S2 p. S130-
1 p.
 artikel
319 308 poster Treatment of unresectable rectal cancers 2004
 71 S2 p. S132-
1 p.
 artikel
320 238 poster TRUS- and CT-image fusion“ in the postplanning procedure after transperineal permanent interstitial seedimplantation (TPSI) of “low risk” prostate cancer 2004
 71 S2 p. S105-
1 p.
 artikel
321 332 poster Update of HDR-brachytherapy for non-malignant obstruction in lung transplant bronchi: two years experiences 2004
 71 S2 p. S140-
1 p.
 artikel
322 237 poster Urethral geometric sparing factor for HDR prostate brachytherapy 2004
 71 S2 p. S105-
1 p.
 artikel
323 234 poster Urinary function after prostate brachytherapy with rapid-strand 125-I in low-risk prostate cancer 2004
 71 S2 p. S104-
1 p.
 artikel
324 275 poster Urinary toxicity when using high dose rate prostate brachytherapy as a boost to conventional external beam radiation therapy in localized prostate cancer 2004
 71 S2 p. S119-
1 p.
 artikel
325 230 poster Variation regarding the calibration certificate and uncertainties in the calibration of air-kerma strength reference (AKSR) of Amersham 6711 Iodine-125 seeds 2004
 71 S2 p. S102-
1 p.
 artikel
326 221 poster What percent of seeds need to be detected for effective intraoperative dosimetry during permanent prostate brachytherapy? 2004
 71 S2 p. S99-
1 p.
 artikel
327 31 Primary standards for brachytherapy sources, emitting betas and low energy photons 2004
 71 S2 p. S15-
1 p.
 artikel
328 102 Reporting time-dose pattern in intra-cavitary brachytherapy. Considerations on a common language using the linear quadratic model 2004
 71 S2 p. S50-S51
2 p.
 artikel
329 30 The differences in approach to source calibration between the US and the EU 2004
 71 S2 p. S15-
1 p.
 artikel
330 101 The role of radiobiology in the management of cervix cancer 2004
 71 S2 p. S50-
1 p.
 artikel
331 62 Three year update of results with the MammoSite breast brachytherapy applicator 2004
 71 S2 p. S31-
1 p.
 artikel
                             331 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland